TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TREATMENT WITH AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF TTR (ISIS-TTR RX)

被引：0
作者：
Benson, M. D. [1 ]
Ackermann, E. J. [2 ]
Monia, B. [2 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] ISIS Pharmaceut Inc, Carlsbad, CA USA
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP)
    Montagna, P
    Marchello, L
    Plasmati, R
    Ferlini, A
    Patrosso, MC
    Salvi, F
    ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1996, 101 (05): : 423 - 430
  • [22] Monoclonal antibodies specifically targeting amyloidogenic forms of transthyretin (TTR) with potential to treat TTR-related cardiomyopathy and polyneuropathy
    Galant, Natalie J.
    Galant, Natalie J.
    Higaki, Jeffrey N.
    Ghosh, Punam
    Hadley, Kevin C.
    Tam, Stephen J.
    Flanagan, Ken
    Nijjar, Tarlochan
    Torres, Ronald
    PROTEIN SCIENCE, 2017, 26 : 205 - 205
  • [23] ALN-TTR, AN RNAI THERAPEUTIC FOR THE TREATMENT OF TRANSTHYRETIN (TTR) AMYLOIDOSIS, MEDIATES REGRESSION OF PERIPHERAL TTR PROTEIN DEPOSITS IN A TRANSGENIC MOUSE MODEL
    Alvarez, Rene
    Borland, Todd
    Costelha, Susete
    Chen, Qingmin
    Nechev, Lubomir
    Jeffs, Lloyd B.
    Sah, Dinah W.
    Saraiva, Maria Joao
    HEPATOLOGY, 2010, 52 (04) : 577A - 578A
  • [24] Familial Amyloid Cardiomyopathy Due to TTR Mutations: An underground Cause of Restrictive Cardiomyopathy
    Ruberg, Frederick L.
    Judge, Daniel P.
    Maurer, Matthew S.
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (05) : 464 - 464
  • [25] Kennen, um zu erkennen: Late Onset Transthyretin-Amyloid Polyneuropathie (TTR-FAP)The Importance of Recognizing: Late Onset Transthyretin Amyloid Polyneuropathy (TTR-FAP)
    Helmut Rauschka
    psychopraxis. neuropraxis, 2019, 22 (4) : 155 - 159
  • [26] Amyloid formation process of transthyretin (TTR) in oxidative stress-induced rats
    Hata, K
    Ando, Y
    Nakagawa, K
    Ishizaki, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 133P - 133P
  • [27] Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)
    Ikeda, K.
    Kano, O.
    Ito, H.
    Kawase, Y.
    Iwamoto, K.
    Sato, R.
    Sekine, T.
    Nagata, R.
    Nakamura, Y.
    Hirayama, T.
    Iwasaki, Y.
    NEUROLOGY, 2008, 70 (17) : 1576 - 1576
  • [28] Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis
    Escolano-Lozano, Fabiola
    Barreiros, Ana Paula
    Birklein, Frank
    Geber, Christian
    BRAIN AND BEHAVIOR, 2018, 8 (01):
  • [29] Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)
    Plante-Bordeneuve, V.
    Ferreira, A.
    Lalu, T.
    Zaros, C.
    Lacroix, C.
    Adams, D.
    Said, G.
    NEUROLOGY, 2007, 69 (07) : 693 - 698
  • [30] Heterogeneity of Phenotypes in Transthyretin-Familial Amyloid Polyneuropathies (TTR-FAP)
    Adams, David
    Lozeron, Pierre
    Misrahi, Micheline
    Theaudin, Marie
    Mincheva, Zoia
    Lacroix, Catherine
    NEUROLOGY, 2011, 76 (09) : A111 - A111
12345